文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Reply to: Can circulating CD34+ cells count be used for the prognosis of myelofibrosis? Probably yes, at least in patients treated with ruxolitinib
复制论文ID
分享
摘要
作者
参考文献
暂无分享,去
创建一个
D. Consonni
|
A. Iurlo
|
D. Cattaneo
|
C. Bucelli
|
Nicole Galli
|
S. Artuso
保存到论文桶